As shown in Table II, 10 of the 15 studies reported that high/positive ERCC1 expression in patients with GC was associated with poor survival, three studies indicated no association between ERCC1 expression and survival, and two studies exhibited an inverse association. Here, ERCC1 is linked to gastric cancer.